Literature DB >> 23218826

The role of preoperative transarterial embolization in spinal tumors. A large single-center experience.

Ruth Thiex1, Mitchel B Harris, Corey Sides, Christopher M Bono, Kai U Frerichs.   

Abstract

BACKGROUND CONTEXT: Patients with spinal tumors are often referred for preoperative angiography and embolization before surgical resection to minimize intraoperative bleeding.
PURPOSE: The purpose of the present study was to investigate the angiographic appearance of a variety of spinal tumors, assess the safety and efficacy of preoperative embolization in relation to the amount of intraoperative blood loss, and correlate intraoperative tumor histology with the degree of gadolinium enhancement on spinal magnetic resonance imaging (MRI) and tumor vascularity visualized during angiography. STUDY DESIGN/
SETTING: Retrospective and single-institution cohort study. PATIENT SAMPLE: One hundred four patients with spinal tumors referred for preoperative embolization. OUTCOME MEASURES: Effectiveness of preoperative embolization in relation to intraoperative blood loss and number of transfused packed red blood cell units in perioperative period (72 hours).
METHODS: From 2000 to 2009, 104 patients with spinal tumors underwent 114 spinal angiographies with the intent to embolize feeder vessels before surgery. The effectiveness of embolization was compared with the documented intraoperative blood loss. Angiographic tumor vascularity was graded from 0 (avascular) to 3 (highly vascular). Ninety-four patients had a pre- and post-gadolinium-enhanced MRI of the spine before transarterial embolization. Magnetic resonance imaging vascular enhancement was classified as Grade 3 (avid contrast enhancement), Grade 2 (moderate), or Grade 1 (mild).
RESULTS: Transarterial tumor embolization was angiographically complete in 63 (66%) and partial in 33 procedures (34%). In 18 cases, the target was not deemed suitable for embolization. A limited statistical analysis did not reveal a statistical difference in documented intraoperative blood loss between patients with complete versus partial embolization for the entire cohort or when stratified into renal cell carcinoma (RCC; p=.64), multiple myeloma (p=.28), malignant (p=.17) and benign tumor groups (p=.26). There were no clinical complications associated with embolization. There was poor correlation between MRI enhancement and angiographic vascularity.
CONCLUSIONS: Preoperative embolization was angiographically effective in most cases. Avid gadolinium enhancement (Grade 3) on MRI was not predictive of hypervascularity on angiography. Furthermore, hypervascularity was not restricted to classically vascular tumors, such as RCC, as it was noted in some patients with breast and prostate cancer. However, with the available numbers, the quality of preoperative embolization did not significantly affect intraoperative blood loss. A future prospective randomized controlled study may be warranted to better characterize the benefits of preoperative embolization for spinal tumors.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23218826     DOI: 10.1016/j.spinee.2012.10.031

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  15 in total

1.  Surgical treatment of spinal metastases from renal cell carcinoma-effects of preoperative embolization on intraoperative blood loss.

Authors:  Matthias Reitz; Klaus Christian Mende; Christopher Cramer; Theresa Krätzig; ZSuzsanna Nagy; Eik Vettorazzi; Sven Oliver Eicker; Marc Dreimann
Journal:  Neurosurg Rev       Date:  2017-11-30       Impact factor: 3.042

2.  Risk factors for major complications in surgery for hypervascular spinal tumors: an analysis of 120 cases with adjuvant preoperative embolization.

Authors:  Benqiang Tang; Tao Ji; Xiaodong Tang; Long Jin; Sen Dong; Wei Guo
Journal:  Eur Spine J       Date:  2015-07-18       Impact factor: 3.134

3.  The role of preoperative vascular embolization in surgery for metastatic spinal tumours.

Authors:  Naresh Kumar; Barry Tan; Aye Sandar Zaw; Hnin Ei Khine; Karthikeyan Maharajan; Leok Lim Lau; Prapul Chander Rajendran; Anil Gopinathan
Journal:  Eur Spine J       Date:  2016-03-11       Impact factor: 3.134

4.  Pre-operative embolisation of spinal metastasis: technique, complication rate and outcome-clinical experience.

Authors:  Patrick Cernoch; Lukas Hechelhammer; Alexander von Hessling; Christian Spross; Johannes Erhardt; Bernhard Jost; Fabrice A Külling
Journal:  Int Orthop       Date:  2015-04-29       Impact factor: 3.075

5.  Preoperative embolization and local hemostatic agents in palliative decompression surgery for spinal metastases of renal cell carcinoma.

Authors:  Nikita Zaborovskii; Dmitrii Ptashnikov; Dmitrii Mikaylov; Sergei Masevnin; Oleg Smekalenkov
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-03-10

6.  Not All Patients Undergoing Stabilization of Impending Pathologic Fractures for Renal Cell Carcinoma Metastases to the Femur Need Preoperative Embolization.

Authors:  Edward W Jernigan; Joshua N Tennant; Robert J Esther
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

7.  Preoperative embolization of primary bone tumors: A case control study.

Authors:  Roushan Jha; Raju Sharma; Shishir Rastogi; Shah Alam Khan; Arvind Jayaswal; Shivanand Gamanagatti
Journal:  World J Radiol       Date:  2016-04-28

Review 8.  Update on Preoperative Embolization of Bone Metastases.

Authors:  Jingqin Ma; Thomas Tullius; Thuong G Van Ha
Journal:  Semin Intervent Radiol       Date:  2019-08-19       Impact factor: 1.513

9.  Dynamic contrast-enhanced MRI for the assessment of spinal tumor vascularity: correlation with angiography.

Authors:  Xiao-Xi Meng; Yong-Qiu Zhang; Hua-Qiang Liao; Hong-Chao Liu; Hai-Lin Jiang; Shu-Jun Ke; Wei-Hua Dong
Journal:  Eur Spine J       Date:  2016-07-23       Impact factor: 3.134

10.  Preoperative embolization versus local hemostatic agents in surgery of hypervascular spinal tumors.

Authors:  Dmitry Ptashnikov; Nikita Zaborovskii; Dmitry Mikhaylov; Sergei Masevnin
Journal:  Int J Spine Surg       Date:  2014-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.